高磊，中国医学科学院病原生物学研究所研究员，博士生导师。作为项目负责人承担了国家传染病科技重大专项、国家自然科学基金、中国医学科学院医学与健康科技创新工程和国际合作等多项科研项目。主要从事结核病流行病学和干预研究。作为第一作者或通讯作者在Lancet Infectious Diseases，European Respiratory Journal等国际学术期刊发表SCI论文50余篇。入选教育部“新世纪优秀人才”、北京市“科技新星”、协和新星等。获得中国防痨协会科学技术一等奖、中华预防医学会科学技术一等奖、中华医学科学技术二等奖、中国医学科学院“杰出贡献奖”、中国医学科学院-法国梅里埃研究院“青年科学家奖”。兼任国家传染病标准专业委员会委员、中国防痨协会标准化专业分会秘书长、国家健康科普专家库成员，以及中国防痨杂志、BMC Infectious Diseases、PLOS Global Public Health、Chronic Diseases and Translational Medicine等杂志编委。

Lei Gao Ph.D. Prof., from the Institute of Pathogen Biology of Chinese Academy of Medical Sciences & Peking Union Medical college. He is an epidemiologist engaged in the research of the pathogenesis and intervention of Tuberculosis. In recent years, his team mainly worked on developing preventive intervention tools and strategies suitable to Chinese conditions for populations at risk of developing active disease from latent tuberculosis infection. Their series of scientific findings have been cited by the national guideline on TB control (2021) and the WHO issued guideline on TB preventive treatment (2020). Prof. Gao serves as the National Infectious Disease Standardization Committee member and the secretary general of the Standardization Branch of China Anti-Tuberculosis Association. He also serves as editorial member of China anti-Tuberculosis journal, PLOS Global Public Health, BMC infection diseases and Chronic Diseases and Transitional Medicine.